A novel 15-hydroxyeicosatrienoic acid-substituted diacylglycerol (15-HETrE-DAG) selectively inhibits epidermal protein kinase C-

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1349, Issue 1, 1997, Pages 67-71

  Cho, Yunhi ^a   A Ziboh, Vincent ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

15 HETrE; 15 HETrE DAG; Epidermis; PKC; PKC

Indexed keywords

15 HYDROXYICOSATRIENOIC ACID; DIACYLGLYCEROL; ISOENZYME; PROTEIN KINASE C; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; EPIDERMIS; GUINEA PIG; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031560235     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(97)00144-6     Document Type: Article

References (30)

1. Nishizuka Y. Science. 258:1992;607-614.
2. Hug H., Sarre T.F. Biochem. J. 291:1993;329-343.
3. Berra E., Diaz-Meco M.T., Dominguez I., Municio M.M., Sanz L., Lozano J., Chapkin R.S., Moscat J. Cell. 74:1993;555-563.
4. Dlugosz A.A., Cheng C., Williams E.K., Dharia A.G., Denning M.F., Yuspa S.H. Cancer Res. 54:1994;6320-6413.
5. Whitfield J.F., Issacs R.J., Jouishomme H., MacLean S., Chakravarthy B.R., Morley P., Barisoni D., Raglia E., Armato U. J. Cell Physiol. 166:1996;1-11.
6. Osada S., Hashimoto Y., Nomura S., Kohno Y., Chida K., Tajima O., Kubo K., Akimoto K., Koizumi H., Kitamura Y., Suzuki K., Ohno S., Kuroki T. Cell. Growth Differ. 4:1993;167-175.
7. Inohara S., Tatsumi Y., Tanaka H., Tateishi H., Sagami S. Arch. Dermatol. Res. 280:1988;454-455.
8. Willis, A.L., Smith, D.I., 1989. In: Spiller, G.A., Scala J. (Eds.), New Protective Roles for Selected Nutrients. Alan R. Liss, New York, pp. 39-108.
9. Lovel C.R., Burton J.L., Horrobin D.F. Lancet. 1(8214):1981;278.
10. Wright S., Burton J.L. Lancet. 2(8303):1982;1120-1122.
11. Tate G., Mandell B.F., Laposata M., Ohliger D., Baker D.G., Schumacher H.R., Zurier R.B. J. Rheumatol. 16:1989;729-733.
12. Kunkel S.L., Ogawa H., Conran P.B., Ward P.A., Zurier R.B. Prog. Lipid. Res. 20:1981;886-888.
13. Mõrk-Hansen T., Lerche A., Kassis V., Lorenzen I., Sondergaard J. Scand. J. Rheumatol. 12:1983;85-88.
14. Tate G., Mandell B.F., Karmali R.A., Laposata M., Baker D.G., Schumacher H.R., Zurier R.B. Arthritis Rheum. 31:1988;1543-1551.
15. Tate G., Mandell B.F., Laposata M., Ohliger D., Baker D.G., Schumacher H.R., Zurier R.B. J. Rheumatol. 16:1989;1729-1736.
16. Miller C.C., McCready C.A., Jones A.D., Ziboh V.A. Prostaglandins. 35:1988;917-938.
17. Miller, C.C., Tang, W., Cho, Y., Ziboh, V.A., 1991. Prostaglandins, Leukotrienes, Lipoxin and PAF. Plenum Press, New York, pp. 409-419.
18. Legrand A.B., Lawson B.O., Meyrick I.A., Oates J.A. J. Biol. Chem. 266:1991;7570-7577.
19. Brezinski M.E., Serhan C.N. Proc. Natl. Acad. Sci. 87:1990;6248-6252.
20. Cho Y., Ziboh V.A. J. Lipid Res. 35:1994;921-931.
21. Qu Y., Torchia J., Phan T.D., Sen A.K. Mol. Cell. Biochem. 103:1991;171-180.
22. Mori T., Takai Y., Yu B., Takahashi J., Nishizuka Y., Fujikura T. J. Biochem. 91:1982;427-431.
23. Kikkawa U., Takai Y., tanaka Y., Miyake R., Nishizuka Y. J. Biol. Chem. 258:1983;11442-11445.
24. Nishizuka Y. Nature. 308:1984;693-698.
25. Kikkawa U., Nishizuka Y. Annu. Rev. Cell. Biol. 2:1986;148-178.
26. Ganong B.R., Loomis C.R., Hannun Y.A., Bell R.M. Proc. Natl. Acad. Sci. USA. 83:1986;1184-1188.
27. Molleyres L.P., Rando R.R. J. Biol. Chem. 263:1988;14832-14838.
28. Miller C.C., Ziboh V.A. Biochem. Biophys. Res. Commun. 154:1988;967-974.
29. Ziboh V.A., Fletcher M.P. J. Clin. Nutr. 55:1992;39-45.
30. Miller C.C., McCreedy C.A., Jones D.A., Ziboh V.A. Prostaglandins. 35:1988;917-938.